The law firm said in a press release it is “investigating possible breaches of fiduciary duty and other violations of law by the board of directors of INSU Acquisition Corp. II” in connection with the company’s proposed merger with digital insurance platform Metromile. The proposed transaction implies an estimated pro forma enterprise value of $956 million.
WeissLaw said it is investigating whether the INSU board “acted in the best interest of shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of Metromile, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to INAQ public shareholders.” Read more.
Related Posts
CA Healthcare Sets Vote Date on LumiraDx Deal
The SPAC's Form S-4 outlining the proposed merger with LumiraDx has been declared effective by the SEC.
Mercer Park Deadline Extension on $567M Glass House Merger Leads to Heavy Redemptions
The SPAC said more than 22 million shares were redeemed in connection with the extension. That leaves approximately $266 million in the SPAC's trust, including an $85 million PIPE expected to close concurrently with the transaction.
Vector Acquisition Sets Vote Date on $4.1B Rocket Lab Deal
The transaction includes up to $320 million of cash held in Vector Acquisition’s trust and a $470 million PIPE.
Belong Acquisition Shares & Warrants to Begin Separate Trading
The tech-focused SPAC has said it will target high-growth technology and tech-enabled businesses in sectors such as e-commerce, software, and digital media.